Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation
Rhea-AI Summary
Visionary (Nasdaq: GV) completed an equity adjustment on Oct 17, 2025 and obtained a 51% controlling stake in Sikang (Guangzhou) Health Industry Investment, turning a prior strategic cooperation into capital-driven control.
The move aims to combine Visionary's global capital channels with Guangzhou Sikang's TCM operating ecosystem to scale standardized TCM health preservation services domestically and internationally, including September 22, 2025 market entry in Malaysia and an October 7, 2025 Panyu cooperation conference with over 200 partners.
Forward-looking risks cited include changes in global demand, cross-border compliance adjustments, intensified competition, and potential operational inefficiencies.
Positive
- Acquired 51% control of joint venture on Oct 17, 2025
- Launched initial Malaysia expansion on Sept 22, 2025
- Held Panyu cooperation conference on Oct 7, 2025 with 200 partners
Negative
- Cross-border compliance adjustments could hinder expansion
- Intensified industry competition may pressure margins
- Potential for lower-than-expected joint venture operating efficiency
News Market Reaction – GV
In the Oct 17 session, GV gained 3.25%, reflecting a moderate positive market reaction. Argus tracked a peak move of +11.1% during that session. Argus tracked a trough of -6.8% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
I. Deepened Strategic Synergy: A Logical Closed Loop from Cooperation to Controlling Stake
As an enterprise deeply engaged in the TCM health preservation sector, Guangzhou Sikang has long been guided by the mission of "revitalizing TCM and inheriting the quintessence of Chinese culture." It has built an industrial ecosystem centered on three core pillars: "professional talent education and training," "standardized brand chain expansion," and "intelligent industrial resource trading," and has developed a mature operational model for the standardization and large-scale implementation of TCM health preservation services.
Based on its judgment of the long-term value of the TCM health preservation track and recognition of Guangzhou Sikang's business foundation, Visionary signed an investment agreement with Guangzhou Sikang in December 2024 to jointly establish the aforementioned Joint Venture Company, initially establishing a strategic cooperation framework. After the completion of this equity adjustment, the cooperation between the two parties has evolved from "strategic synergy" to an in-depth integration model of "capital empowerment + industrial collaboration." Through its controlling stake, Visionary will further integrate its global capital channels, cross-border resource connection capabilities, and Guangzhou Sikang's industrial operation experience to drive the systematic global layout of the Joint Venture Platform in the TCM health preservation sector.
II. Business Support for the Joint Venture Platform: Dual-track Progress in Domestic Deepening and International Expansion
Prior to the equity adjustment, Guangzhou Sikang had already achieved phased progress in both "localized operation" and "international exploration" of its TCM health preservation business, providing a business foundation for the subsequent development of the Joint Venture Platform:
1.Initial Expansion into the Southeast Asian Market: On September 22, 2025, relying on the international communication platform of the "Miss & Mrs. Gaia World Pageant Finals," Guangzhou Sikang introduced core TCM products and services such as moxibustion and head therapy into the Southeast Asian market. Currently, this business has received support from local partners in
2.Upgraded Domestic Channel Synergy: On October 7, 2025, Guangzhou Sikang held the "TCM Health Preservation Ecosystem Cooperation Conference" in Panyu,
III. Strategic Value and Shareholder Returns: The Long-term Logic of Capital-Industry Resonance
Regarding this controlling stake transaction, Visionary's management stated: "As an important segment of the global large health industry, TCM health preservation has long-term growth potential. Guangzhou Sikang's localized operation capabilities and international exploration direction in this sector are highly aligned with Visionary's core strategy of 'focusing on global high-quality industries and creating sustainable shareholder value.' After taking control, the Company will empower the Joint Venture Platform in three aspects: first, providing compliant capital support to ensure business expansion meets domestic and foreign regulatory requirements; second, connecting Visionary's global industrial channels to facilitate the cross-border implementation of TCM health preservation services and products; third, integrating technologies and resources to promote service standardization and scaling, striving to build the Joint Venture Platform into a compliant operation carrier for the globalization of TCM health preservation."
It is disclosed that after the completion of the equity adjustment, the Joint Venture Platform will explore a collaborative model of "TCM health preservation service operation + cross-border industrial resource integration + compliant dissemination of traditional culture" within a regulatory framework. On one hand, it will meet the health needs of global consumers through a standardized service system; on the other hand, it will promote the international recognition of TCM health preservation concepts through compliant cultural dissemination channels. Ultimately, this will help Visionary build a dual growth curve of "industrial investment + business operation" and create long-term value for shareholders.
IV. Risk Factors
This press release contains "forward-looking statements" as defined in Section 27A of the
About Visionary Holdings Inc. (Nasdaq: GV)
Visionary Holdings Inc. (Nasdaq: GV) is a Nasdaq-listed company focused on global high-quality industry investment. It is committed to deploying in segments with long-term growth potential through capital integration, resource connection, and compliant operations to create sustainable value for global shareholders. The Company has always adhered to domestic and foreign regulatory requirements, attached importance to investor relations management, and safeguarded investors' right to information through regular information disclosure and transparent communication.
View original content:https://www.prnewswire.com/news-releases/visionary-completes-controlling-stake-in-sikang-health-industry-joint-venture-platform-deepening-global-layout-of-tcm-health-preservation-302586599.html
SOURCE Visionary Holdings Inc.